Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization

World Journal of Gastroenterology

Volumn 18, Issue 26, 2012, Pages 3443-3450

  Lai, Wei ^a   Lu, Shi Chun ^a   Li, Guan Yin ^a   Li, Chuan Yun ^a   Wu, Ju Shan ^a   Guo, Qing Liang ^a   Wang, Meng Long ^a   Li, Ning ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anticoagulation regimen; Portal or splenic vein thrombosis; Portal vein hypertension; Splenectomy with gastroesophageal devascularization; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; DEVASCULARIZATION; FEMALE; GASTROESOPHAGEAL DEVASCULARIZATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SPLENECTOMY; SPLENIC VEIN; THROMBOCYTE; TREATMENT DURATION;

EID: 84863922129     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i26.3443     Document Type: Article

References (51)

1. Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashi-ta N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Mae-hara Y. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 2010; 97: 910-916
2. Yoshida M, Watanabe Y, Horiuchi A, Yamamoto Y, Sug-ishita H, Kawachi K. Portal and splenic venous thrombosis after splenectomy in patients with hypersplenism. Hepato-gastroenterology 2009; 56: 538-541
3. Fujita F, Lyass S, Otsuka K, Giordano L, Rosenbaum DL, Khalili TM, Phillips EH. Portal vein thrombosis following splenectomy: identifcation of risk factors. Am Surg 2003; 69: 951-956
4. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-741
5. Chaffanjon PC, Brichon PY, Ranchoup Y, Gressin R, Sotto JJ. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging. World J Surg 1998; 22: 1082-1086
6. Skarsgard E, Doski J, Jaksic T, Wesson D, Shandling B, Ein S, Babyn P, Heiss K, Hu X. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J Pediatr Surg 1993; 28: 1109-1112
7. Hassn AM, Al-Fallouji MA, Ouf TI, Saad R. Portal vein thrombosis following splenectomy Br J Surg 2000; 87: 362-373
8. Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 2005; 241: 208-216
9. Ikeda M, Sekimoto M, Takiguchi S, Yasui M, Danno K, Fujie Y, Kitani K, Seki Y, Hata T, Shingai T, Takemasa I, Ikenaga M, Yamamoto H, Ohue M, Monden M. Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment. Am J Surg 2007; 193: 21-25
10. Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsut-sumi N, Tomikawa M, Maehara Y. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010; 251: 76-83
11. Ushitora Y, Tashiro H, Takahashi S, Amano H, Oshita A, Kobayashi T, Chayama K, Ohdan H. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 2011; 28: 9-14
12. Deng MH, Liu B, Fang HP, Pan WD, Tang ZF, Deng P, Zhong YS, Xu RY. Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis. World J Gastroenterol 2007; 13: 6588-6592
13. Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepato-biliary Pancreat Dis Int 2005; 4: 515-518
14. Ramos AP, Reigada CP, Ataíde EC, Almeida JR, Cardoso AR, Caruy CA, Stucchi RS, Boin IF. Portal vein thrombosis and liver transplantation: long term. Transplant Proc 2010; 42: 498-501
15. Orlando G, De Luca L, Toti L, Zazza S, Angelico M, Cas-ciani CU, Tisone G. Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplant Proc 2004; 36: 199-202
16. Sharma R, Kashyap R, Jain A, Safadjou S, Graham M, Dwivedi AK, Orloff M. Surgical complications following liver transplantation in patients with portal vein thrombosis--a single-center perspective. J Gastrointest Surg 2010; 14: 520-527
17. Suarez Artacho G, Barrera Pulido L, Alamo Martinez JM, Serrano Diez-Canedo J, Bernal Bellido C, Marín Gomez LM, Padillo Ruiz J, Gómez Bravo MA. Outcomes of liver transplantation in candidates with portal vein thrombosis. Transplant Proc 2010; 42: 3156-3158
18. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010; 16: 83-90
19. Wang H, Kopac D, Brisebois R, Sample C, Shapiro AM. Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy. Can J Surg 2011; 54: 227-231
20. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J. Prospective study of the incidence and risk factors of postsplenecto-my thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006; 141: 663-669
21. Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis 2009; 1: e2009014
22. Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tor-tora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolf R, Gasbarrini A. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16: 143-155
23. Krauth MT, Lechner K, Neugebauer EA, Pabinger I. The postoperative splenic/portal vein thrombosis after splenec-tomy and its prevention--an unresolved issue. Haematologica 2008; 93: 1227-1232
24. Sun YW, Chen W, Luo M, Hua R, Liu W, Huo YM, Wu ZY, Cao H. Evaluation of surgical procedure selection based on intraoperative free portal pressure measurement in patients with portal hypertension. Hepatobiliary Pancreat Dis Int 2010; 9: 269-274
25. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolf R, Gasbarrini A. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-689
26. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007; 7: 34
27. Spahr L, Boehlen F, de Moerloose P, Hadengue A. Anticoagulants in portal vein thrombosis: don't be so shy! Blood 2009; 113: 5031-5032; author reply 5032
28. Romano F, Caprotti R, Conti M, Piacentini MG, Uggeri F, Motta V, Pogliani EM, Uggeri F. Thrombosis of the spleno-portal axis after splenectomy. Langenbecks Arch Surg 2006; 391: 483-488
29. Rattner DW, Ellman L, Warshaw AL. Portal vein thrombosis after elective splenectomy. An underappreciated, potentially lethal syndrome. Arch Surg 1993; 128: 565-569; discussion 569-570
30. Park AE, Birgisson G, Mastrangelo MJ, Marcaccio MJ, Wit-zke DB. Laparoscopic splenectomy: outcomes and lessons learned from over 200 cases. Surgery 2000; 128: 660-667
31. Woodruff RS, Sullenger B, Becker RC. The many faces of the contact pathway and their role in thrombosis. J Thromb Thrombolysis 2011; 32: 9-20
32. Romualdi E, Ageno W. Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes. Expert Opin Investig Drugs 2011; 20: 495-505
33. Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG. Anticoagulation by factor Xa inhibitors. J Thromb Hae-most 2010; 8: 1745-1753
34. Turpie AG. Pharmacology of the low-molecular-weight heparins. Am Heart J 1998; 135: S329-S335
35. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Hal-perin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 64S-94S
36. Bechmann LP, Sichau M, Wichert M, Gerken G, Kröger K, Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 2011; 31: 75-82
37. Paikin JS, Wright DS, Eikelboom JW. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials. Blood Rev 2011; 25: 123-129
38. Bollati M, Gaita F, Anselmino M. Antiplatelet combinations for prevention of atherothrombotic events. Vasc Health Risk Manag 2011; 7: 23-30
39. Kuzniatsova N, Lip GY. Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible? Int J Cardiol 2011; 148: 1-3
40. Mavrakanas T, Bounameaux H. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther 2011; 130: 46-58
41. van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000; 87: 1229-1233
42. Yerdel MA, Gunson B, Mirza D, Karayalçin K, Olliff S, Buckels J, Mayer D, McMaster P, Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69: 1873-1881
43. Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME. Portal vein thrombosis after splenectomy. Am J Surg 2002; 184: 631-635; discussion 635-636
44. Ponziani FR, Zocco MA, Tortora A, Gasbarrini A. Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? Expert Opin Pharmacother 2010; 11: 1479-1487
45. Schäfer C, Zundler J, Bode JC. Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature. Eur J Gastroenterol Hepatol 2000; 12: 1141-1145
46. Lopera JE, Correa G, Brazzini A, Ustunsoz B, Patel S, Jan-chai A, Castaneda-Zuniga W. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002; 36: 1058-1061
47. Pan C, Shi Y, Zhang JJ, Deng YL, Zheng H, Zhu ZJ, Shen ZY. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc 2009; 41: 3761-3765
48. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000; 32: 466-470
49. Soyer T, Ciftci AO, Tanyel FC, Senocak ME, Büyük-pamukçu N. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome. J Pediatr Surg 2006; 41: 1899-1902
50. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis -- new insights into a etiology and management. Aliment Pharmacol Ther 2005; 21: 1-9
51. Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease. World J Gastroenterol 2008; 14: 176-179